Targeting <i>HER2</i> Exon 20 Insertion–Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib
2021 · Cancer Research · 55 citations
https://doi.org/10.1158/0008-5472.can-21-1526
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
30
Papers
1.8K
Citations
17
h-index
17
i10-index
Michael Fitzgerald is an academic researcher from Seattle University. The author has contributed to research in topics: Ubiquitin and proteasome pathways & Multiple Myeloma Research and Treatments & Immune Cell Function and Interaction. The author has an h-index of 17, co-authored 26 publications.
ORCID: 0009-0007-7533-942Xhttps://doi.org/10.1158/0008-5472.can-21-1526
https://doi.org/10.1016/j.celrep.2022.111674
Click to start Chat